Model Hirano bodies protect against tau-independent and tau-dependent cell death initiated by the amyloid precursor protein intracellular domain.
The main pathological hallmarks of Alzheimer's disease are amyloid-beta plaques and neurofibrillary tangles, which are primarily composed of amyloid precursor protein (APP) and tau, respectively. These proteins and their role in the mechanism of neurodegeneration have been extensively studied....
Main Authors: | Matthew Furgerson, Marcus Fechheimer, Ruth Furukawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3445605?pdf=render |
Similar Items
-
Transgenic mouse model for the formation of Hirano bodies
by: Stramiello Michael, et al.
Published: (2011-10-01) -
De novo actin polymerization is required for model Hirano body formation in Dictyostelium
by: Yun Dong, et al.
Published: (2016-06-01) -
Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation
by: Woo Shik Shin, et al.
Published: (2019-10-01) -
Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
by: Niklas Mattsson‐Carlgren, et al.
Published: (2021-06-01) -
Amyloid‐dependent and amyloid‐independent effects of Tau in individuals without dementia
by: Joseph Therriault, et al.
Published: (2021-10-01)